Last reviewed · How we verify
NCT05043480
Pilot Study On Pulsed Electromagnetic Field Therapy For Osteosarcopenia
NA trial testing PEMF in Sarcopenia in 80 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | Louis Tee |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 October 2021 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- PEMF
Conditions studied
- Sarcopenia — all drugs for Sarcopenia →
- Osteopenia or Osteoporosis — all drugs for Osteopenia or Osteoporosis →
Sponsor
Louis Tee
Who can join
Adults 65 to 100, any sex, with Sarcopenia or Osteopenia or Osteoporosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective, single-site, single arm pilot study aims to assess the efficacy of Pulsed Electromagnetic Field (PEMF) exposure in the reduction of the decline in muscle strength, function and bone mineral density (BMD) in osteosarcopenia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05043480
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PEMF
Trials testing the same drug.
- NCT06969859 — Pulsed Electro-Magnetic Field Therapy for Treatment of Midportion Achilles Tendinopathy · NA · recruiting
- NCT06196567 — Pulsed Electromagnetic Field Therapy on Muscle Strength and Function in Patients With End-stage of Knee Osteoarthritis · NA · recruiting
- NCT05501210 — Vibration on Patellofemoral Joint Pain After ACLR · NA · recruiting
- NCT04590456 — Pulsed Electromagentic Field in Haemophilia · NA · unknown
- NCT02643836 — Pulsed Electromagnetic Field (PEMF) Therapy for Post-Concussive Syndrome · NA · withdrawn
Other recruiting trials for Sarcopenia
Currently open trials in the same condition.
- NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
- NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
- NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05043480 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Louis Tee
- Last refreshed: 14 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05043480.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing